n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Cardiac Diseases in 1 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, M | 1 |
| Chen, JY | 1 |
| Chao, ML | 1 |
| Zhang, C | 1 |
| Shi, ZG | 1 |
| Zhou, XC | 1 |
| Xie, LP | 1 |
| Sun, SX | 1 |
| Huang, ZR | 1 |
| Luo, SS | 1 |
| Ji, Y | 1 |
1 other study available for n-(3-(aminomethyl)benzyl)acetamidine and Cardiac Diseases
| Article | Year |
|---|---|
S-nitrosylation of c-Jun N-terminal kinase mediates pressure overload-induced cardiac dysfunction and fibrosis.
Topics: Angiotensin II; Animals; Aorta; Fibroblasts; Fibrosis; Heart Diseases; Humans; Imines; JNK Mitogen-A | 2022 |